National Competition Commission Calls for Regulatory Overhaul

In a move aimed at fostering greater competition, Argentina’s National Competition Commission has issued a strong recommendation to the Ministry of Agriculture and Senasa (National Agri-Food Health and Quality Service) to revise the regulations governing the Aphy Fever vaccine market. the recommendation, while non-binding, signals a potential shift towards a more open and competitive landscape for vaccine producers and distributors.

Background: Complaint Against Dominant Players

The recommendation follows a nearly year-long complaint filed by Tecnovax, a laboratory seeking to introduce a vaccine from Brazil, alleging cartelization and a dominant market position held by Bagó Biogenesis and the Veterinary Diagnostic Center (CDV), both established vaccine manufacturers. The Rural Society of south Salta had also lodged a similar complaint.Tecnovax has so far declined to comment on the official decision.

Key Recommendations for Senasa

the commission’s recommendations focus on several key areas:

Expanding Access to Vaccination Services

The commission argues that current regulations unnecessarily restrict competition by limiting who can provide vaccination services and in which geographical areas.they suggest broadening the pool of eligible providers and allowing multiple foundations, health entities, or veterinary suppliers to operate within the same region, giving producers more choice.

Reassessing Vaccine Registration Requirements

A central point of contention is the Podal Generalization Protection test (PGP), a requirement for vaccine registration that some consider overly burdensome. The commission advises Senasa to review the PGP requirement and consider replacing it or allowing it to coexist with validated indirect tests, such as the Elisa-CFL method, which are considered simpler and equally reliable. The PGP test involves bringing animals from Aphyosa-free zones, like Patagonia, to a Senasa-approved center to observe the vaccine’s effectiveness.

Current regulations unnecessarily limit competition in the distribution and inoculation of vaccines against Afitase fever when restricting who can provide vaccination services and in which geographical areas can it do.

One industry source noted the uniqueness of Argentina’s exclusive reliance on the PGP test for new competitors, regardless of prior approval and triumphant commercialization in other regional countries.They emphasized that the subsequent antibody evaluation using the Elisa method is the globally recognized standard for control.

Recognizing Equivalence for Vaccines

The commission also advocates for the recognition of “equivalence” for vaccines, similar to the existing practice for active ingredients in phytosanitary products. This would involve considering the authorization of Aphy Fever vaccines manufactured in countries with a proven track record of effectiveness, as outlined in Resolution No.694 dated June 26, 2024.

Streamlining Manufacturing Practices

Further recommendations include recognizing the equivalence of Good Manufacturing Practices (GMP) certificates issued by countries with stringent regulatory standards similar to Argentina’s.

Implications for Regional Competitors

The current regulations exclude Brazil, Uruguay, Paraguay, and Bolivia from the automatic equivalence list, creating a significant barrier for potential regional competitors. The commission’s recommendations aim to address this disparity and promote greater regional trade.

Recommendations for the Ministry of Agriculture

Along with the recommendations for Senasa,the commission also addressed the Ministry of Agriculture regarding the health entities established in collaboration with producers in the 1990s to combat the disease,which were later recreated after a resurgence in 2001.

Revising Registration Requirements for health Entities

The commission proposes reviewing the registration requirements for health entities to broaden the pool of eligible registrants, allowing multiple entities to operate within the same region, and granting producers the freedom to choose their supplier for implementing required health policies.

Eliminating Geographical Restrictions

The commission also advises eliminating geographical restrictions that limit the operational area of specific entities, thereby expanding producers’ choices and fostering greater competition, potentially leading to reduced costs for sanitary services.

Allowing Free Tariff Setting

the commission suggests allowing health entities to freely set tariffs for specific services agreed upon with third parties within the framework of Senasa-approved programs or plans.

Potential Impact on Argentina’s Livestock Industry

If implemented, these regulatory changes could significantly impact Argentina’s livestock industry by fostering greater competition, potentially lowering vaccine costs, and improving access to vaccination services. This could lead to enhanced disease control and improved productivity for Argentine livestock producers. According to recent data from the World Organisation for Animal Health (WOAH), Aphy Fever remains a significant threat to livestock populations globally, highlighting the importance of effective vaccination strategies.